294 related articles for article (PubMed ID: 34729701)
41. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
42. Control of Dissolution and Supersaturation/Precipitation of Poorly Water-Soluble Drugs from Cocrystals Based on Solubility Products: A Case Study with a Ketoconazole Cocrystal.
Kataoka M; Yonehara A; Minami K; Takagi T; Yamashita S
Mol Pharm; 2023 Aug; 20(8):4100-4107. PubMed ID: 37354097
[TBL] [Abstract][Full Text] [Related]
43. Physicomechanical, stability, and pharmacokinetic evaluation of aceclofenac dimethyl urea cocrystals.
Afzal H; Abbas N; Hussain A; Latif S; Fatima K; Arshad MS; Bukhari NI
AAPS PharmSciTech; 2021 Feb; 22(2):68. PubMed ID: 33564940
[TBL] [Abstract][Full Text] [Related]
44. Gabapentin-saccharin co-crystals with enhanced physicochemical properties and
Soliman II; Kandil SM; Abdou EM
Pharm Dev Technol; 2020 Feb; 25(2):227-236. PubMed ID: 31671004
[TBL] [Abstract][Full Text] [Related]
45. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
[TBL] [Abstract][Full Text] [Related]
46. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.
Al-Kazemi R; Al-Basarah Y; Nada A
Adv Pharm Bull; 2019 Oct; 9(4):559-570. PubMed ID: 31857959
[No Abstract] [Full Text] [Related]
47. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
48. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
Ming X; Thakker DR
Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
[TBL] [Abstract][Full Text] [Related]
49. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters.
Bhalla Y; Chadha K; Chadha R; Karan M
Heliyon; 2019 Nov; 5(11):e02669. PubMed ID: 31763466
[TBL] [Abstract][Full Text] [Related]
50. Impact of polymeric excipient on cocrystal formation via hot-melt extrusion and subsequent downstream processing.
Karimi-Jafari M; Ziaee A; Iqbal J; O'Reilly E; Croker D; Walker G
Int J Pharm; 2019 Jul; 566():745-755. PubMed ID: 31212053
[TBL] [Abstract][Full Text] [Related]
51. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies.
Dodiya S; Chavhan S; Korde A; Sawant KK
Drug Dev Ind Pharm; 2013 May; 39(5):733-43. PubMed ID: 22690834
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes.
Darsazan B; Shafaati A; Zarghi A; Mortazavi SA
J Pharm Pharm Sci; 2018; 21(1):160-170. PubMed ID: 29789103
[TBL] [Abstract][Full Text] [Related]
53. Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization.
Cao F; Amidon GL; Rodriguez-Hornedo N; Amidon GE
Mol Pharm; 2016 Mar; 13(3):1030-46. PubMed ID: 26877267
[TBL] [Abstract][Full Text] [Related]
54. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations.
Renkoğlu P; Çelebier M; Arıca-Yegin B
Pharm Dev Technol; 2015 May; 20(3):380-4. PubMed ID: 24521464
[TBL] [Abstract][Full Text] [Related]
55. Cocrystal Construction Between Rosuvastatin Calcium and L-asparagine with Enhanced Solubility and Dissolution Rate.
Vemuri VD; Lankalapalli S
Turk J Pharm Sci; 2021 Dec; 18(6):790-798. PubMed ID: 34979738
[TBL] [Abstract][Full Text] [Related]
56. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
Aitipamula S; Das S
Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
[TBL] [Abstract][Full Text] [Related]
57. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
Yamashita H; Sun CC
Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
[TBL] [Abstract][Full Text] [Related]
58. Exploring potential coformers for oxyresveratrol using principal component analysis.
Ouiyangkul P; Tantishaiyakul V; Hirun N
Int J Pharm; 2020 Sep; 587():119630. PubMed ID: 32652183
[TBL] [Abstract][Full Text] [Related]
59. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.
Chow SF; Chen M; Shi L; Chow AH; Sun CC
Pharm Res; 2012 Jul; 29(7):1854-65. PubMed ID: 22359146
[TBL] [Abstract][Full Text] [Related]
60. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.
Remenar JF; Peterson ML; Stephens PW; Zhang Z; Zimenkov Y; Hickey MB
Mol Pharm; 2007; 4(3):386-400. PubMed ID: 17497886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
